Ultra-high sensitivity cardiac troponin-I concentration and left ventricular structure and function in women with

Odayme Quesada1,2, Omeed Elboudwarej1, Michael D Nelson3

  • 1Barbra Streisand Women's Heart Center, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America.

Insights

Cardiomyocyte injury, indicated by ultra-high sensitivity cardiac troponin I (u-hscTnI), is linked to left ventricular (LV) remodeling and dysfunction in women with ischemia and no obstructive coronary artery disease (INOCA). Further research is needed to clarify the exact mechanisms.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Biomarker Research

Background:

  • Women with ischemia and no obstructive coronary artery disease (INOCA) face a higher risk of heart failure with preserved ejection fraction (HFpEF).
  • The underlying mechanisms connecting INOCA to HFpEF remain poorly understood, particularly regarding cardiomyocyte injury.

Purpose of the Study:

  • To investigate the association between ultra-high sensitivity cardiac troponin I (u-hscTnI), a marker of cardiomyocyte injury, and myocardial perfusion, left ventricular (LV) structure, and function in women with INOCA.

Main Methods:

  • Analysis of 327 women with INOCA from the WISE-CVD study.
  • Utilized vasodilator stress cardiac magnetic resonance imaging (CMRI) and u-hscTnI measurements.
  • Employed multivariable linear regression to assess relationships between u-hscTnI and LV mass index, and feature-tracking derived strain measures.

Main Results:

  • Quantifiable u-hscTnI levels were found in 100% of participants.
  • Elevated u-hscTnI concentrations were significantly associated with increased LV mass index and altered early diastolic strain rates (radial, circumferential, and longitudinal).
  • No significant association was observed between u-hscTnI and myocardial perfusion reserve index (MPRI).

Conclusions:

  • Cardiomyocyte injury, as indicated by u-hscTnI, may contribute to adverse LV remodeling and dysfunction in women with INOCA.
  • These findings suggest a potential pathway linking INOCA to HFpEF through myocellular injury.
  • Further research is required to elucidate the specific mechanisms driving cardiomyocyte injury in INOCA.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
70
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
327
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
24
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
65